Related Experiment Video
Updated: Jul 8, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Beyond the laboratory: clinical implications for statin pleiotropy
Julian P J Halcox1, John E Deanfield
1Vascular Physiology Unit, Department of Cardiology, Institute of Child Health, University College London, London, England.
Circulation
|June 3, 2004
Summary
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, offer benefits beyond lipid lowering. Current evidence suggests cholesterol reduction remains the primary driver of their clinical effectiveness.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Atherosclerosis Research
Background:
- 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) have revolutionized atherosclerosis management.
- Statins impact lipid levels and influence inflammatory, oxidative, and thrombotic pathways.
- These pleiotropic effects may contribute to observed clinical benefits beyond lipid modification.
Purpose of the Study:
- To review clinical evidence for statin benefits independent of lipid-lowering effects.
- To explore statin utility in conditions not typically linked to high cholesterol.
- To assess if benefits precede lipid level changes and if magnitude is cholesterol-independent.
Main Methods:
- Review of clinical trial data and scientific literature.
- Analysis of evidence examining pleiotropic effects of statins.
- Evaluation of the relationship between clinical outcomes and lipid reduction.
Main Results:
- While statins possess pleiotropic effects, low-density-lipoprotein (LDL) lowering is currently considered the primary mechanism for clinical benefits.
- Evidence for significant clinical benefits independent of LDL reduction is limited.
- The magnitude of clinical benefit generally correlates with the degree of LDL cholesterol reduction.
Conclusions:
- Low-density-lipoprotein lowering remains the principal mechanism driving the clinical benefits of statin therapy.
- Statin therapy should continue to focus on lipid reduction for cardiovascular risk mitigation.
- Further research may elucidate the role and extent of pleiotropic effects in specific contexts.
More Related Videos
Related Concept Videos
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...